Ronald Kamdem Analyst Performance

Ronald Kamdem is a stock analyst at Morgan Stanley, covering 15 publicly traded companies across a range of sectors. Over the past year, Ronald Kamdem has issued 22 stock ratings, including buy, hold, and sell recommendations. While full access to Ronald Kamdem's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ronald Kamdem's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Analyst Rating

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

23 Last 3 Years

Buy Recommendations

43.48% 10 Buy Ratings

Companies Covered

15 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	43.5%	10 ratings
Hold	47.8%	11 ratings
Sell	8.7%	2 ratings

Out of 23 total stock ratings issued by Ronald Kamdem at Morgan Stanley, the majority (47.8%) have been Hold recommendations, followed by 43.5% Buy and 8.7% Sell.

Best & Worst Calls

• Best Call

  000.0%

  ADC

  Jul 2022

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NYSE	80.0% of companies on NYSE	12 companies
NASDAQ	20.0% of companies on NASDAQ	3 companies

Ronald Kamdem, an analyst at Morgan Stanley, currently covers 15 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector Icon	Sector	Percentage
	Finance 14 companies	93.3%
	Medical 1 company	6.7%

Ronald Kamdem of Morgan Stanley specializes in stock coverage within the Finance sector, with additional focus on Medical companies.

Coverage Industries

Industry	Percentage
REIT - EQTY TRUST - OTHER 10 companies	66.7%
REIT - EQTY TRUST - RETAIL 3 companies	20.0%
REAL ESTATE OPS 1 company	6.7%
NURSING & PERSONAL CARE FACILITIES 1 company	6.7%

Ronald Kamdem's Ratings History at Morgan Stanley

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Time Frame

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
FVR FrontView REIT	7/11/2025	Downgrade	$12.13	$13.50	Equal Weight	$0.00 00.00% ROI
VICI VICI Properties	7/8/2025	Boost Price Target	$32.94	$35.00	Equal Weight	$0.00 00.00% ROI
LINE Lineage	6/23/2025	Downgrade	$44.76	$50.00	Equal Weight	$0.00 00.00% ROI
CBRE CBRE Group	6/12/2025	Reiterated Rating	$136.03	$170.00	Overweight	$0.00 00.00% ROI
SNDA Shanda Interactive Entertainment	5/20/2025	Boost Price Target	$25.91	$26.00	Equal Weight	$0.00 00.00% ROI
AHR American Healthcare REIT	5/20/2025	Boost Price Target	$35.38	$45.00	Overweight	$0.00 00.00% ROI
WELL Welltower	5/6/2025	Boost Price Target	$150.93	$160.00	Overweight	$0.00 00.00% ROI
CURB Curbline Properties	4/24/2025	Lower Price Target	$23.22	$26.00	Equal Weight	$0.00 00.00% ROI
CBRE CBRE Group	4/24/2025	Lower Price Target	$126.06	$160.00	Overweight	$0.00 00.00% ROI
HPP Hudson Pacific Properties	4/15/2025	Reiterated Rating	$2.21	$1.75	Underweight	$0.00 00.00% ROI
PLD Prologis	4/14/2025	Lower Price Target	$102.33	$120.00	Outperform	$0.00 00.00% ROI
MAC Macerich	4/1/2025	Lower Price Target	$17.12	$19.00	Equal Weight	$0.00 00.00% ROI
LINE Lineage	4/1/2025	Lower Price Target	$56.90	$75.00	Overweight	$0.00 00.00% ROI
AHR American Healthcare REIT	3/25/2025	Boost Price Target	$30.28	$37.00	Overweight	$0.00 00.00% ROI
PGRE Paramount Group	3/18/2025	Lower Price Target	$4.13	$4.00	Equal Weight	$0.00 00.00% ROI
HPP Hudson Pacific Properties	3/18/2025	Lower Price Target	$2.98	$2.25	Underweight	$0.00 00.00% ROI
VNO Vornado Realty Trust	3/14/2025	Boost Price Target	$36.61	$28.00	Equal Weight	$0.00 00.00% ROI
CBRE CBRE Group	2/19/2025	Boost Price Target	$142.00	$165.00	Overweight	$0.00 00.00% ROI
CURB Curbline Properties	1/29/2025	Initiated Coverage	$25.27	$27.00	Equal Weight	$0.00 00.00% ROI
CBRE CBRE Group	1/15/2025	Upgrade	$124.82	$160.00	Overweight	$0.00 00.00% ROI
MAC Macerich	1/15/2025	Upgrade	$19.43	$20.00	Equal Weight	$0.00 00.00% ROI
GLPI Gaming and Leisure Properties	1/15/2025	Downgrade	$46.91	$53.00	Equal Weight	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.